HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Inui, Y. Articles by Davidson, N. O. Search for Related Content PubMed PubMed Citation Articles by Inui, Y. Articles by Davidson, N. O. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 33, 1843-1856, Copyright © 1992 by Lipid Research, Inc.

ARTICLES

Apolipoprotein B messenger RNA editing in rat liver: developmental and hormonal modulation is divergent from apolipoprotein A-IV gene expression despite increased hepatic lipogenesis

Y Inui, AM Hausman, N Nanthakumar, SJ Henning and NO Davidson
Department of Medicine, University of Chicago, IL 60637.

Rat hepatic apolipoprotein B (apoB) mRNA editing is regulated developmentally as well as by hormonal and nutritional modulation of hepatic lipogenesis, changes previously associated with coordinate modulation of hepatic apoA-IV gene expression. We have examined the effects of dexamethasone administration on apoB mRNA editing and the expression of other apolipoprotein genes in both neonatal and adult rats. Administration of dexamethasone increased hepatic triglyceride content in neonatal rats and increased hepatic but not intestinal apoA- IV mRNA abundance. However, neither the developmental profile nor the extent of hepatic apoB mRNA editing was changed after hormone administration. Dexamethasone produced a dose-dependent increase in adult hepatic triglyceride content and a coordinate fourfold increase in hepatic but not intestinal apoA-IV mRNA abundance, and hepatic and serum apoA-IV protein concentrations. Immunocytochemical localization revealed apoA-IV to be expressed in hepatocytes around the central vein while dexamethasone treatment produced a dose-dependent appearance of fat-filled hepatocytes throughout the lobule that were immunoreactive for apoA-IV. Despite these changes in hepatic triglyceride accumulation there was no change in the extent of hepatic apoB mRNA editing at any dose of dexamethasone. The data suggest that hormonal and metabolic modulation of hepatic apoB mRNA editing may be independent of factors that modulate apoA-IV gene expression despite alterations in hepatic triglyceride content.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				V. Blanc, J. O. Henderson, R. D. Newberry, Y. Xie, S.-J. Cho, E. P. Newberry, S. Kennedy, D. C. Rubin, H. L. Wang, J. Luo, et al. Deletion of the AU-Rich RNA Binding Protein Apobec-1 Reduces Intestinal Tumor Burden in Apcmin Mice Cancer Res., September 15, 2007; 67(18): 8565 - 8573. [Abstract] [Full Text] [PDF]

				D. M. Lehmann, C. A. Galloway, M. P. Sowden, and H. C. Smith Metabolic regulation of ApoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor Nucleic Acids Res., July 4, 2006; 34(11): 3299 - 3308. [Abstract] [Full Text] [PDF]

				D. Mukhopadhyay, M. Plateroti, S. Anant, F. Nassir, J. Samarut, and N. O. Davidson Thyroid Hormone Regulates Hepatic Triglyceride Mobilization and Apolipoprotein B Messenger Ribonucleic Acid Editing in a Murine Model of Congenital Hypothyroidism Endocrinology, February 1, 2003; 144(2): 711 - 719. [Abstract] [Full Text] [PDF]

				M. A. Ostos, D. Recalde, N. Baroukh, A. Callejo, M. Rouis, G. Castro, and M. M. Zakin Fructose Intake Increases Hyperlipidemia and Modifies Apolipoprotein Expression in Apolipoprotein AI-CIII-AIV Transgenic Mice J. Nutr., May 1, 2002; 132(5): 918 - 923. [Abstract] [Full Text] [PDF]

				D. Plonne, H.-P. Schulze, U. Kahlert, K. Meltke, H. Seidolt, A. J. Bennett, I. J. Cartwright, J. A. Higgins, U. Till, and R. Dargel Postnatal development of hepatocellular apolipoprotein B assembly and secretion in the rat J. Lipid Res., November 1, 2001; 42(11): 1865 - 1878. [Abstract] [Full Text] [PDF]

				B. Teng, B. Ishida, T. M. Forte, S. Blumenthal, L.-Z. Song, A. M. Gotto Jr, and L. Chan Effective Lowering of Plasma, LDL, and Esterified Cholesterol in LDL Receptor–Knockout Mice by Adenovirus-Mediated Gene Delivery of ApoB mRNA Editing Enzyme (Apobec1) Arterioscler. Thromb. Vasc. Biol., May 1, 1997; 17(5): 889 - 897. [Abstract] [Full Text]

				T. J. Kalogeris, M.-D. Rodriguez, and P. Tso Control of Synthesis and Secretion of Intestinal Apolipoprotein A-IV by Lipid J. Nutr., March 1, 1997; 127(3): 537 - 537. [Abstract] [Full Text]

				T. Igura, S. Kawata, J.-i. Miyagawa, Y. Inui, S. Tamura, K. Fukuda, K. Isozaki, K. Yamamori, N. Taniguchi, S. Higashiyama, et al. Expression of Heparin-Binding Epidermal Growth Factor–Like Growth Factor in Neointimal Cells Induced by Balloon Injury in Rat Carotid Arteries Arterioscler. Thromb. Vasc. Biol., December 1, 1996; 16(12): 1524 - 1531. [Abstract] [Full Text]

				C.-N. Wang, R. S. McLeod, Z. Yao, and D. N. Brindley Effects of Dexamethasone on the Synthesis, Degradation, and Secretion of Apolipoprotein B in Cultured Rat Hepatocytes Arterioscler. Thromb. Vasc. Biol., September 1, 1995; 15(9): 1481 - 1491. [Abstract] [Full Text]